Completion of Placing & WRAP to raise £8.75m
30 October 2026
Verici Dx plc
(“Verici Dx” or the “Company”)
Completion of Placing and Retail Offer to raise £8.75m
Directors’ Shareholdings
Verici Dx Plc, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, is pleased to confirm that following the passing of the Resolutions at the Shareholders’ General Meeting on Tuesday 27 October 2026, 2,691,999,983 new Ordinary Shares have been admitted to trading on AIM. The Company has raised total gross proceeds of £8.75m (net proceeds of £8.13m) through the Placing and WRAP Retail Offer.
As previously announced, Julian Baines and Sara Barrington, both directors of the Company, participated in the Placing. Following Admission of the Conditional Placing Shares their shareholdings are as set out below:
Previous Holding
Share Placing Participation
Shareholding following Admission
Shares
%
Shares
Shares
%
Julian Baines
8,548,482
0.37%
10,000,000
18,548,482
0.28%
Sara Barrington
8,285,715
0.36%
5,000,000
13,285,715
0.20%
Capitalised terms used but not otherwise defined in this announcement have the meanings set out in the Circular published on 10 August 2026.
Enquiries:
Verici Dx plc
Sara Barrington, CEO
Via Walbrook PR
Julian Baines, Chairman
Singer Capital Markets (Nominated Adviser & Joint Broker)
Tel: +44 (0)20 7496 3000
Russell Cook / Anastassiya Eley / Harry Littlewood
Oberon Capital (Joint Broker)
Tel: +44 (0)20 3179 0500
Mike Seabrook / Heena Karani
Walbrook PR (Media & Investor Relations)
Tel: +44 (0)20 7933 8780 or vericidx@walbrookpr.com
Alice Woodings / Rachel Broad
Mob: +44 (0)7407 804 654 / +44 (0)7747 515 393
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Julian Baines
2
Reason for the notification
a)
Position/status
Non-Executive Chairman
b)
Initial notification / Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Verici Dx plc
b)
LEI
213800FI5WE4FVQ3G645
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.1 pence each
ISIN: GB00BM8HZD43
b)
Nature of the transaction
Placing participation of new ordinary shares
c)
Price(s) and volume(s)
Price: 0.2 pence
Volume: 10,000,000 shares
d)
Aggregated information
N/A
e)
Date of the transaction
28 October 2026
f)
Place of the transaction
Outside of trading venue - off market
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Sara Barrington
2
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification / Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Verici Dx plc
b)
LEI
213800FI5WE4FVQ3G645
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.1 pence each
ISIN: GB00BM8HZD43
b)
Nature of the transaction
Placing participation of new ordinary shares
c)
Price(s) and volume(s)
Price: 0.2 pence
Volume: 5,000,000 shares
d)
Aggregated information
N/A
e)
Date of the transaction
28 October 2026
f)
Place of the transaction
Outside of trading venue - off market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHDZMFGGGZGVZM
